BIOMAT Database Logo BIOMAT Database Logo

Sudden-Onset Catatonia Following Clozapine Withdrawal: A Case Report. 2016

Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
ivan.koychev@doctors.org.uk.

UI MeSH Term Description Entries
D008140 Lorazepam A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Apo-Lorazepam,Ativan,Donix,Duralozam,Durazolam,Idalprem,Laubeel,Lorazep Von Ct,Lorazepam Medical,Lorazepam-Neuraxpharm,Lorazepam-Ratiopharm,Novo-Lorazem,Nu-Loraz,Orfidal Wyeth,Sedicepan,Sinestron,Somagerol,Temesta,Tolid,Témesta,WY-4036,Apo Lorazepam,Lorazepam Neuraxpharm,Lorazepam Ratiopharm,Medical, Lorazepam,Novo Lorazem,Nu Loraz,Von Ct, Lorazep,WY 4036,WY4036,Wyeth, Orfidal
D008297 Male Males
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D009465 Neuromuscular Agents Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (NEUROMUSCULAR BLOCKING AGENTS), and drugs that act centrally as skeletal muscle relaxants (MUSCLE RELAXANTS, CENTRAL). Drugs used in the treatment of movement disorders are ANTI-DYSKINESIA AGENTS. Skeletal Muscle Relaxants,Neuromuscular Effect,Neuromuscular Effects,Agents, Neuromuscular,Effect, Neuromuscular,Effects, Neuromuscular,Muscle Relaxants, Skeletal,Relaxants, Skeletal Muscle
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002389 Catatonia A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994) Catatonia, Malignant,Catatonia, Organic,Lethal Catatonia,Organic Catatonic Disorder,Schizophreniform Catatonia,Catatonia, Lethal,Catatonia, Schizophreniform,Catatonias,Catatonias, Lethal,Catatonias, Malignant,Catatonias, Organic,Catatonias, Schizophreniform,Catatonic Disorder, Organic,Catatonic Disorders, Organic,Lethal Catatonias,Malignant Catatonia,Malignant Catatonias,Organic Catatonia,Organic Catatonias,Organic Catatonic Disorders,Schizophreniform Catatonias
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D003620 Dantrolene Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants. Dantrium,Dantrolene Sodium,Sodium, Dantrolene

Related Publications

Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Sudden onset catatonia following tricyclic antidepressant withdrawal - A case report.
November 2023, Indian journal of psychiatry,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Clozapine withdrawal catatonia: A case report.
July 2023, Indian journal of psychiatry,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Clozapine Withdrawal Catatonia: A Case Report.
January 2024, Cureus,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Clozapine withdrawal-induced catatonia treated with clozapine: A case report.
February 2023, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Catatonia secondary to clozapine withdrawal: A case report.
December 2023, Journal of the neurological sciences,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report.
September 1997, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Clozapine-withdrawal catatonia.
March 2009, The Australian and New Zealand journal of psychiatry,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Clozapine-withdrawal catatonia.
January 2010, Psychosomatics,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Catatonia Due to Clozapine Withdrawal: A Case Report and Literature Review.
January 2019, Psychosomatics,
Ivan Koychev, and Savvas Hadjiphilippou, and Joanna Lynch, and Paul Whelan, and James MacCabe
Severe Catatonia Following Sudden Withdrawal of Quetiapine.
December 2022, The primary care companion for CNS disorders,
Copied contents to your clipboard!